BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10485646)

  • 1. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder.
    Goldstein TR; Frye MA; Denicoff KD; Smith-Jackson E; Leverich GS; Bryan AL; Ali SO; Post RM
    J Clin Psychiatry; 1999 Aug; 60(8):563-7; quiz 568-9. PubMed ID: 10485646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar depression and antidepressant-induced mania: a naturalistic study.
    Boerlin HL; Gitlin MJ; Zoellner LA; Hammen CL
    J Clin Psychiatry; 1998 Jul; 59(7):374-9. PubMed ID: 9714266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-induced mania in bipolar patients: identification of risk factors.
    Henry C; Sorbara F; Lacoste J; Gindre C; Leboyer M
    J Clin Psychiatry; 2001 Apr; 62(4):249-55. PubMed ID: 11379838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature.
    Ali S; Milev R
    Can J Psychiatry; 2003 May; 48(4):258-64. PubMed ID: 12776393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
    Narayan V; Haddad PM
    J Psychopharmacol; 2011 Mar; 25(3):306-13. PubMed ID: 20156925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
    Peet M
    Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age effects on antidepressant-induced manic conversion.
    Martin A; Young C; Leckman JF; Mukonoweshuro C; Rosenheck R; Leslie D
    Arch Pediatr Adolesc Med; 2004 Aug; 158(8):773-80. PubMed ID: 15289250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
    Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
    Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
    Grunze H; Dittmann S
    MMW Fortschr Med; 2003 May; 145 Suppl 2():27-30. PubMed ID: 14579481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
    Nemeroff CB; Evans DL; Gyulai L; Sachs GS; Bowden CL; Gergel IP; Oakes R; Pitts CD
    Am J Psychiatry; 2001 Jun; 158(6):906-12. PubMed ID: 11384898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discontinuation syndrome associated with antidepressants].
    Pitchot W; Scantamburlo G; Pinto E; Ansseau M
    Rev Med Liege; 2007 Oct; 62(10):624-7. PubMed ID: 18069574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant treatment in bipolar versus unipolar depression.
    Ghaemi SN; Rosenquist KJ; Ko JY; Baldassano CF; Kontos NJ; Baldessarini RJ
    Am J Psychiatry; 2004 Jan; 161(1):163-5. PubMed ID: 14702267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm.
    Nolen WA; Bloemkolk D
    Neuropsychobiology; 2000; 42 Suppl 1():11-7. PubMed ID: 11093064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
    Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J
    J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.
    Biederman J; Mick E; Bostic JQ; Prince J; Daly J; Wilens TE; Spencer T; Garcia-Jetton J; Russell R; Wozniak J; Faraone SV
    J Clin Psychiatry; 1998 Nov; 59(11):628-37; quiz 638. PubMed ID: 9862614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.